Management of Heavy Menstrual Bleeding in Patients Taking Oral Contraceptive Pills
First-Line Management
- The American College of Obstetricians and Gynecologists recommends adding tranexamic acid (TXA) to the existing oral contraceptive pill (OCP) regimen as the first-line treatment option for patients experiencing heavy menstrual bleeding despite using OCPs, with 53% of specialists recommending this combination, and it should be used during days of bleeding for 5-7 days to effectively reduce blood flow without changing the hormonal regimen 1, 2, 3
- Before initiating treatment, it is essential to rule out underlying gynecological problems such as pregnancy, STDs, medication interactions, or pathologic uterine conditions (e.g., polyps or fibroids) 3
Second-Line Options
- If bleeding persists despite TXA + OCP combination, consider switching to a levonorgestrel-releasing intrauterine device (LNG-IUD), which was recommended by 51% of specialists as second-line therapy, and is highly effective for controlling heavy menstrual bleeding, resulting in 71-95% reduction in menstrual blood loss 1, 4, 5
- Nonsteroidal anti-inflammatory drugs (NSAIDs) such as mefenamic acid, indomethacin, or flufenamic acid for 5-7 days during bleeding episodes can be used as an alternative second-line option 2, 6
Special Considerations
- For patients with bleeding disorders of unknown cause, the combination of TXA with OCPs is particularly important as these patients may have underlying hemostatic abnormalities 1
- Aspirin should be avoided as it has shown no significant improvement in menstrual blood loss and may worsen bleeding in some cases 6
- Enhanced counseling about expected bleeding patterns can significantly reduce method discontinuation 6
Important Caveats
- If bleeding persists despite treatment and is unacceptable to the patient, consider alternative contraceptive methods 2
- In patients with active thromboembolic disease or history/risk of thrombosis, TXA should be used with caution or avoided 6